Achari Ventures Holdings Corp. I (AVHI)
| Previous close | 11.20 |
| Open | 11.20 |
| Bid | 11.20 x 40000 |
| Ask | 11.49 x 40000 |
| Day's range | 11.20 - 11.20 |
| 52-week range | 8.00 - 12.45 |
| Volume | |
| Avg. volume | 451 |
| Market cap | 31.461M |
| Beta (5Y monthly) | 0.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.81 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireStateHouse Reports First Quarter 2024, Fourth Quarter 2023, and Full Year 2023 Financial Results
Q1 2024 Gross Margin Remains Strong at 46.5% Gains in Cultivation Output and Market Share Amidst Successful Cost Reductions Now Positioned as 4th Largest Cannabis Brand Operator in California Kevin K. Albert Appointed to the Board of Directors SAN DIEGO and TORONTO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc. (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQB: STHZF), a California-focused, vertically integrated cannabis company, today announced its financial results for the three-
- PR Newswire
Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger
Vaso Corporation ("Vaso," or "the Company"), a diversified medical technology company currently trading on the OTCQX market, today announced its plan to uplist from the OTCQX market to the Nasdaq Stock Market via a business combination (the "Transaction") with Achari Ventures Holdings Corp. I ("Achari", NASDAQ:AVHI). Upon the closing of the Transaction, Vaso common stock and warrants are expected to be listed on Nasdaq Capital Market ("Nasdaq") under the ticker symbols "VASO" and "VASOW", respec
